A record of what Amit Khurana said publicly, with the source. Not advice.
DC
Amit Khurana
Track record
Building a track record
Graded calls
0 hit · 0 miss
Pending
0 awaiting resolution
Scored on trackable calls only. Long-horizon and commentary opinions are listed below but not counted in this score.
Recent calls
Newest first. Every call links back to its original source.
| Call | Instrument | Verdict | Actions |
|---|---|---|---|
| “Amit Khurana views Sun Pharma's recent acquisition as strategically sound and directionally correct for long-term growth…” | Sun Pharma | — | |
| “Amit Khurana of Dolat Capital is positive on India Inc's aggregate earnings, noting that Q3 earnings held up well and op…” | Nifty 50 | — | |
| “Amit Khurana of Dolat Capital is positive on Hindustan Unilever (HUL) and the broader FMCG sector, particularly premium …” | Hindustan Unilever | — | |
| “Amit Khurana of Dolat Capital expects the IT sector, including Infosys and TCS, to remain broadly range-bound in the int…” | Infosys | — | |
| “Advises a neutral stance on the pharma sector for FY26, anticipating a consolidation year. This is due to normalizing ta…” | Nifty Pharma | — | |
| “Recommends a cautious approach, anticipating potential headwinds and a listless market, with a preference for bottom-up …” | Nifty IT | — |